Global Functional Electrical Stimulation Market - 2023-2030
Global Functional Electrical Stimulation Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
Functional electrical stimulation (FES) is a treatment that involves painless, mild electrical stimulation to a muscle or muscles to help them move. Functional Electrical Stimulation helps initiate muscle activity by stimulating the muscles to strengthen muscle activity to reduce muscle spasticity.
FES stimulates the motor nerves to achieve muscle contraction. It is used widely in rehabilitation and maintenance of function where there is muscle weakness or tightness. FES applies low-level electrical impulses to weakened, damaged, or paralyzed muscles to help improve people’s capability and mobility.
Market Dynamics: Drivers & Restraints
Innovations in functional electrical stimulation systems for spinal cord injuries
The increase in innovations and increase in the launch of advanced devices is expected to drive market growth.
For instance, in July 2023, Motive Health introduced the US Food and Drug Administration (FDA)-approved Motive Knee muscle stimulation device.
For instance, in July 2022, Healthtech startup Pulsetto launched a neuromodulation device that stimulates the vagus nerve. Stimulating the vagus nerve with electric impulses activates the parasympathetic nervous system by allowing the body to rest and relax.
Additionally, an increase in chronic pain and the increase in neuromuscular injuries and spinal cord injuries is also expected to drive market growth.
Restraint
Stringent regulations for device approvals
Long approval processes are causing delays in introducing new items to the market. Stringent device licensing regulations and a wide choice of electrical stimulation system alternatives are the factors the market is expected to get hampered in the forecast period.
Additionally, the high cost of the devices and the risks associated with the treatment procedures are expected to hinder market growth.
Segment Analysis
The global functional electrical stimulation market is segmented based on product type, device type, application, end-user and region.
Spinal cord stimulation devices segment accounted for 45.2% of the market share
Spinal cord stimulation uses a mild electrical current to stimulate certain nerve fibers in the spinal cord. Spinal cord stimulation helps in targeted pain relief. The increase in the number of spinal cord injuries and increase in the number of stimulation devices is expected to drive the segment growth.
For instance, in January 2021, Boston Scientific introduced the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) systems.
In December 2022, Abbott launched the world's smallest implantable, rechargeable spinal cord stimulation system for chronic pain. Thus, the increase in the number of spinal cord injuries increases the demand for spinal cord stimulation devices.
Geographical Analysis
North America is expected to hold a significant position in the global functional electrical stimulation market share
North America accounted for the largest market share. The increasing prevalence of chronic pain and increasing injuries and increase in the number of individuals preferring rehabilitation centers is expected to hold the region in the dominant position. Additionally, increasing technological advancements and increasing manufacturing of medical devices are also expected to raise the market growth in the region.
For instance, according to the Centers for Disease Control and Prevention, it is estimated that in 2021, 20.9% of U.S. adults i.e., 51.6 million individuals experienced chronic pain, and 6.9% i.e., approximately 17.1 million individuals experienced high-impact chronic pain.
According to the CDMRP report, it is estimated that there are serious injuries with long-term consequences requiring lifelong care. It is estimated that about 300,000 individuals are living with an SCI, and over 17,000 new cases occur in the U.S. each year. Thus, the above factors are expected to raise the market growth.
COVID-19 Impact Analysis
COVID-19 has had an unprecedented impact on manufacturing companies and the health sector, this is due to the restrictions imposed during the COVID-19 period. Lockdown has created a major challenge in supplying the devices across borders due to the restrictions imposed by the governments and the lack of labor during the period has also affected the market growth.
Market Segmentation
By Product Type
• Wired
• Wireless
By Device Type
• Spinal Cord Stimulation Devices
• Deep Brain Stimulation Devices
• Vagus Nerve Stimulation Devices
• Sacral Nerve Stimulation Devices
• Gastric Electric Stimulation Devices
• Neuromuscular Electrical Stimulation Devices
• Cranial Electrical Stimulation Devices
• Others
By Application
• Pain Management
• Neurological and Movement Disorder Management
• Musculoskeletal Disorder Management
• Incontinence Management
• Others
By End-User
• Hospitals
• Specialty Clinics
• Neurosurgical Centers
• Ambulatory Surgical Centers
• Others
By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The leading companies with a significant market share include Boston Scientific Corporation, AxioBionics Inc., Nevro Corp, Medtronic Plc, NeuroMetrix, Inc., BTL Industries, Inc., Zynex Inc., Abbott Laboratories, Hocoma AG, OMRON Healthcare among others
Key Developments
• In December 2022, the U.S. Food and Drug Administration (FDA) approved Abbott's Eterna spinal cord stimulation (SCS) system for the treatment of chronic pain
• In January 2022, Bioelectronics company NeuroSigma Inc. commercially launched a bioelectronic medical device that uses external trigeminal nerve stimulation (eTNS) to treat children with attention deficit/hyperactivity disorder (ADHD).
• In September 202, Evolution Devices launched its EvoWalk Platform pilot program to rehabilitate walking for people living with neurologically-based partial walking paralysis.
Why Purchase the Report?
• To visualize the global functional electrical stimulation market segmentation based on product type, device type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of functional electrical stimulation treatment market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global functional electrical stimulation market report would provide approximately 69 tables, 75 figures, and 180 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Product Type
- 3.2. Snippet by Device Type
- 3.3. Snippet by Application
- 3.4. Snippet by End-User
- 3.5. Snippet by Region
- 4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Innovations in functional electrical stimulation systems for spinal cord injuries
- 4.1.1.2. XX
- 4.1.2. Restraints
- 4.1.2.1. Stringent regulations for device approvals
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's Five Force Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Regulatory Analysis
- 5.5. Russia-Ukraine War Impact Analysis
- 5.6. DMI Opinion
- 6. COVID-19 Analysis
- 6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
- 6.2. Pricing Dynamics Amid COVID-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
- 7. By Product Type
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
- 7.2. Wired *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Wireless
- 8. By Device Type
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 8.1.2. Market Attractiveness Index, By Route of Administration
- 8.2. Spinal Cord Stimulation Devices*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Deep Brain Stimulation Devices
- 8.4. Vagus Nerve Stimulation Devices
- 8.5. Sacral Nerve Stimulation Devices
- 8.6. Gastric Electric Stimulation Devices
- 8.7. Neuromuscular Electrical Stimulation Devices
- 8.8. Cranial Electrical Stimulation Devices
- 8.9. Others
- 9. By Application
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
- 9.2. Pain Management*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Neurological and Movement Disorder Management
- 9.4. Musculoskeletal Disorder Management
- 9.5. Incontinence Management
- 9.6. Others
- 10. By End-User
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
- 10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 10.3. Specialty Clinics
- 10.4. Neurosurgical Centers
- 10.5. Ambulatory Surgical Centers
- 10.6. Others
- 11. By Region
- 11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
- 11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.2.7.1. U.S.
- 11.2.7.2. Canada
- 11.2.7.3. Mexico
- 11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.3.7.1. Germany
- 11.3.7.2. UK
- 11.3.7.3. France
- 11.3.7.4. Italy
- 11.3.7.5. Spain
- 11.3.7.6. Rest of Europe
- 11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.4.7.1. Brazil
- 11.4.7.2. Argentina
- 11.4.7.3. Rest of South America
- 11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.5.7.1. China
- 11.5.7.2. India
- 11.5.7.3. Japan
- 11.5.7.4. Australia
- 11.5.7.5. Rest of Asia-Pacific
- 11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Market Positioning/Share Analysis
- 12.3. Mergers and Acquisitions Analysis
- 13. Company Profiles
- 13.1. Boston Scientific Corporation*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
- 13.2. AxioBionics Inc.
- 13.3. Nevro Corp
- 13.4. Medtronic Plc
- 13.5. NeuroMetrix, Inc.
- 13.6. BTL Industries, Inc.
- 13.7. Zynex Inc.
- 13.8. Abbott Laboratories
- 13.9. Hocoma AG
- 13.10. OMRON Healthcare
- LIST NOT EXHAUSTIVE
- 14. Appendix
- 14.1. About Us and Services
- 14.2. Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook